The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Glycation Induces Formation of Amyloid Cross-β Structure in Albumin
Open accessAbstract
Amyloid fibrils are components of proteinaceous plaques that are associated with conformational diseases such as Alzheimer's disease, transmissible spongiform encephalopathies, and familial amyloidosis. Amyloid polypeptides share a specific quarternary structure element known as cross-beta structure. Commonly, fibrillar aggregates are modified by advanced glycation end products (AGE). In addition, AGE formation itself induces protein aggregation. Both amyloid proteins and protein-AGE adducts bind multiligand receptors, such as receptor for AGE, CD36, and scavenger receptors A and B type I, and the serine protease tissue-type plasminogen activator (tPA). Based on these observations, we hypothesized that glycation induces refolding of globular proteins, accompanied by formation of cross-beta structure. Using transmission electron microscopy, we demonstrate here that glycated albumin condensates into fibrous or amorphous aggregates. These aggregates bind to amyloid-specific dyes Congo red and thioflavin T and to tPA. In contrast to globular albumin, glycated albumin contains amino acid residues in beta-sheet conformation, as measured with circular dichroism spectropolarimetry. Moreover, it displays cross-beta structure, as determined with x-ray fiber diffraction. We conclude that glycation induces refolding of initially globular albumin into amyloid fibrils comprising cross-beta structure. This would explain how glycated ligands and amyloid ligands can bind to the same multiligand "cross-beta structure" receptors and to tPA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases
Bucciantini, M., Giannoni, E., Chiti, F., Baroni, F., Formigli, L., Zurdo, J., Taddei, N., Ramponi, G., Dobson, C. M., & Stefani, M. (2002) · Nature · doi:10.1038/416507a · Cited by 2,434
Crystal structure of human serum albumin at 2.5 Å resolution
Sugio, S., Kashima, A., Mochizuki, S., Noda, M., & Kobayashi, K. (1999) · Protein Engineering, Design and Selection · doi:10.1093/protein/12.6.439 · Cited by 1,786
Common core structure of amyloid fibrils by synchrotron X-ray diffraction 1 1Edited by F. E. Cohen
Sunde, M., Serpell, L. C., Bartlam, M., Fraser, P. E., Pepys, M. B., & Blake, C. C. F. (1997) · Journal of Molecular Biology · doi:10.1006/jmbi.1997.1348 · Cited by 1,707
[18] Quantification of β-sheet amyloid fibril structures with thioflavin T
LeVine, H. (1999) · Methods in Enzymology · doi:10.1016/s0076-6879(99)09020-5 · Cited by 1,365
Yan, S. D., Schmidt, A. M., Anderson, G. M., Zhang, J., Brett, J., Zou, Y. S., Pinsky, D., & Stern, D. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36966-1 · Cited by 1,306
Designing conditions for in vitro formation of amyloid protofilaments and fibrils
Chiti, F., Webster, P., Taddei, N., Clark, A., Stefani, M., Ramponi, G., & Dobson, C. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3590 · Cited by 1,039
Andrade, M. A., Chacón, P., Merelo, J. J., & Morán, F. (1993) · "Protein Engineering, Design and Selection" · doi:10.1093/protein/6.4.383 · Cited by 1,007
Kislinger, T., Fu, C., Huber, B., Qu, W., Taguchi, A., Du Yan, S., Hofmann, M., Yan, S. F., Pischetsrieder, M., Stern, D., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.44.31740 · Cited by 869
Vlassara, H., Bucala, R., & Striker, L. J. (1994) · PubMed · Cited by 848
Advanced glycation end products contribute to amyloidosis in Alzheimer disease
Vitek, M. P., Bhattacharya, K., Glendening, J. M., Stopa, E., Vlassara, H., Bucala, R., Manogue, K., & Cerami, A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.11.4766 · Cited by 806
Amyloid fibrils from muscle myoglobin
Fändrich, M., Fletcher, M. A., & Dobson, C. M. (2001) · Nature · doi:10.1038/35065514 · Cited by 799
Schmidt, A. M., Yan, S. D., Wautier, J.-L., & Stern, D. (1999) · Circulation Research · doi:10.1161/01.res.84.5.489 · Cited by 791
An investigation of the structure of silk fibroin
Marsh, R. E., Corey, R. B., & Pauling, L. (1955) · Biochimica et Biophysica Acta · doi:10.1016/0006-3002(55)90178-5 · Cited by 721
Balbach, J. J., Ishii, Y., Antzutkin, O. N., Leapman, R. D., Rizzo, N. W., Dyda, F., Reed, J., & Tycko, R. (2000) · Biochemistry · doi:10.1021/bi0011330 · Cited by 703
The biology of the receptor for advanced glycation end products and its ligands
Schmidt, A. M., Yan, S. D., Yan, S. F., & Stern, D. M. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(00)00087-2 · Cited by 691
Amyloid fibril formation by an SH3 domain
Guijarro, J. I., Sunde, M., Jones, J. A., Campbell, I. D., & Dobson, C. M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4224 · Cited by 669
Wells-Knecht, K. J., Zyzak, D. V., Litchfield, J. E., Thorpe, S. R., & Baynes, J. W. (1995) · Biochemistry · doi:10.1021/bi00011a027 · Cited by 595
Islet Amyloid and Type 2 Diabetes Mellitus
Höppener, J. W. M., Ahrén, B., & Lips, C. J. M. (2000) · New England Journal of Medicine · doi:10.1056/nejm200008103430607 · Cited by 521
Coraci, I. S., Husemann, J., Berman, J. W., Hulette, C., Dufour, J. H., Campanella, G. K., Luster, A. D., Silverstein, S. C., & El Khoury, J. B. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64354-4 · Cited by 398
Vlassara, H., Fuh, H., Makita, Z., Krungkrai, S., Cerami, A., & Bucala, R. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.24.12043 · Cited by 377
[19] Quantifying amyloid by congo red spectral shift assay
Klunk, W. E., Jacob, R. F., & Mason, R. P. (1999) · Methods in Enzymology · doi:10.1016/s0076-6879(99)09021-7 · Cited by 351
The principal site of nonenzymatic glycosylation of human serum albumin in vivo.
Garlick, R. L., & Mazer, J. S. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)32384-6 · Cited by 316
Amyloid Fibril Formation from Full-Length and Fragments of Amylin
Goldsbury, C., Goldie, K., Pellaud, J., Seelig, J., Frey, P., Müller, S. A., Kistler, J., Cooper, G. J. S., & Aebi, U. (2000) · Journal of Structural Biology · doi:10.1006/jsbi.2000.4268 · Cited by 316
Yamagishi, S.-I., Inagaki, Y., Okamoto, T., Amano, S., Koga, K., Takeuchi, M., & Makita, Z. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202634200 · Cited by 310
Kume, S., Takeya, M., Mori, T., Araki, N., Suzuki, H., Horiuchi, S., Kodama, T., Miyauchi, Y., & Takahashi, K. (1995) · Europe PMC (PubMed Central) · Cited by 295
Halverson, K., Fraser, P. E., Kirschner, D. A., & Lansbury, P. T. (1990) · Biochemistry · doi:10.1021/bi00463a003 · Cited by 292
Advanced glycation end products: A nephrologist's perspective
Raj, D. S. C., Choudhury, D., Welbourne, T. C., & Levi, M. (2000) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(00)70189-2 · Cited by 290
Receptor for advanced glycation endproducts (RAGE) and the complications of diabetes
STERN, D., YAN, S., YAN, S., & SCHMIDT, A. (2002) · Ageing Research Reviews · doi:10.1016/s0047-6374(01)00366-9 · Cited by 266
Molecular conformation of a peptide fragment of transthyretin in an amyloid fibril
Jaroniec, C. P., MacPhee, C. E., Astrof, N. S., Dobson, C. M., & Griffin, R. G. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.252625999 · Cited by 253
Araki, N., Higashi, T., Mori, T., Shibayama, R., Kawabe, Y., Kodama, T., Takahashi, K., Shichiri, M., & Horiuchi, S. (1995) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1995.0408h.x · Cited by 248
van Zonneveld, A. J., Veerman, H., & Pannekoek, H. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)67006-1 · Cited by 242
TAN, S. Y., & PEPYS, M. B. (1994) · Histopathology · doi:10.1111/j.1365-2559.1994.tb00001.x · Cited by 230
Sousa, M. M., Du Yan, S., Fernandes, R., Guimarães, A., Stern, D., & Saraiva, M. J. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-19-07576.2001 · Cited by 212
Aβ-Induced Inflammatory Processes in Microglia Cells of APP23 Transgenic Mice
Bornemann, K. D., Wiederhold, K.-H., Pauli, C., Ermini, F., Stalder, M., Schnell, L., Sommer, B., Jucker, M., & Staufenbiel, M. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63945-4 · Cited by 206
Neurotoxicity of Advanced Glycation End-Products for Cultured Cortical Neurons
Takeuchi, M., Bucala, R., Suzuki, T., Ohkubo, T., Yamazaki, M., Koike, T., Kameda, Y., & Makita, Z. (2000) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/59.12.1094 · Cited by 198
Bellotti, V., Mangione, P., & Merlini, G. (2000) · Journal of Structural Biology · doi:10.1006/jsbi.2000.4248 · Cited by 190
Münch, G., Mayer, S., Michaelis, J., Hipkiss, A. R., Riederer, P., Müller, R., Neumann, A., Schinzel, R., & Cunningham, A. M. (1997) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(96)00062-2 · Cited by 174
X-ray Diffraction of Scrapie Prion Rods and PrP Peptides
Nguyen, J. T., Inouye, H., Baldwin, M. A., Fletterick, R. J., Cohen, F. E., Prusiner, S. B., & Kirschner, D. A. (1995) · Journal of Molecular Biology · doi:10.1006/jmbi.1995.0507 · Cited by 169
Cytotoxicity of advanced glycation endproducts is mediated by oxidative stress
Loske, C., Neumann, A., Cunningham, A. M., Nichol, K. A., Schinzel, R., Riederer, P. F., & Münch, G. W. (1998) · Journal of Neural Transmission · doi:10.1007/s007020050108 · Cited by 153
Kikuchi, S., Shinpo, K., Moriwaka, F., Makita, Z., Miyata, T., & Tashiro, K. (1999) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19990715)57:2<280::aid-jnr14>3.0.co;2-u · Cited by 149
Schmidt, A.-M., Hofmann, M. A., Taguchi, A., Yan, S. D., & Stern, D. M. (2000) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-2000-13204 · Cited by 134
Chibber, R., Molinatti, P. A., Rosatto, N., Lambourne, B., & KOHNER, E. M. (1997) · Diabetologia · doi:10.1007/s001250050657 · Cited by 133
Chiti, F., Bucciantini, M., Capanni, C., Taddei, N., Dobson, C. M., & Stefani, M. (2001) · Protein Science · doi:10.1110/ps.10201 · Cited by 132
Diabetes mellitus and diabetes-associated vascular disease
Kirpichnikov, D., & Sowers, J. R. (2001) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(01)00391-5 · Cited by 123
Husemann, J., Loike, J. D., Kodama, T., & Silverstein, S. C. (2001) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(01)00239-9 · Cited by 122
Sakata, N., Imanaga, Y., Meng, J., Tachikawa, Y., Takebayashi, S., Nagai, R., & Horiuchi, S. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(98)00192-0 · Cited by 118
Cribbs, D. H., Azizeh, B. Y., Cotman, C. W., & LaFerla, F. M. (2000) · Biochemistry · doi:10.1021/bi000029f · Cited by 113
Tissue-Type Plasminogen Activator Is a Multiligand Cross-β Structure Receptor
Kranenburg, O., Bouma, B., Kroon-Batenburg, L. M. J., Reijerkerk, A., Wu, Y., Voest, E. E., & Gebbink, M. F. B. G. (2002) · Current Biology · doi:10.1016/s0960-9822(02)01224-1 · Cited by 112
Self-citationContribution of advanced glycosylation to the amyloidogenicity of islet amyloid polypeptide
Kapurniotu, A., Bernhagen, J., Greenfield, N. J., Al‐Abed, Y., Teichberg, S., Frank, R. W., Voelter, W., & Bucala, R. (1998) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1998.2510208.x · Cited by 111
Westwood, M. E., Argirov, O. K., Abordo‐Adesida, E., & Thornalley, P. J. (1997) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(96)00154-1 · Cited by 107
Sasaki, N., Takeuchi, M., Chowei, H., Kikuchi, S., Hayashi, Y., Nakano, N., Ikeda, H., Yamagishi, S., Kitamoto, T., Saito, T., et al. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00310-5 · Cited by 105
Morphology and antibody recognition of synthetic β‐amyloid peptides
Fraser, P. E., Duffy, L. K., O'Malley, M. B., Nguyen, J. T., Inouye, H., & Kirschner, D. A. (1991) · Journal of Neuroscience Research · doi:10.1002/jnr.490280404 · Cited by 98
Min, C., Kang, E., Yu, S.-H., Shinn, S.-H., & Kim, Y. (1999) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(99)00094-7 · Cited by 97
Azizeh, B. Y., Cribbs, D. H., Cotman, C. W., & LaFerla, F. M. (2006) · Kluwer Academic Publishers eBooks · doi:10.1007/0-306-46881-6_287 · Cited by 88
Damas, A. M., & Saraiva, M. J. (2000) · Journal of Structural Biology · doi:10.1006/jsbi.2000.4273 · Cited by 86
Jackson, G. S., & Clarke, A. R. (2000) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(99)00051-2 · Cited by 84
Series Introduction: Multiligand receptors and human disease
Krieger, M., & Stern, D. M. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13932 · Cited by 70
Fibrin‐Mediated Plasminogen Activation
Nieuwenhuizen, W. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb03512.x · Cited by 67
Ohgami, N., Nagai, R., Ikemoto, M., Arai, H., Kuniyasu, A., Horiuchi, S., & NAKAYAMAA, H. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb03961.x · Cited by 66
Matsumoto, K., Sano, H., Nagai, R., Suzuki, H. I., Kodama, T., Yoshida, M., Ueda, S., Smedsrød, B. H., & Horiuchi, S. (2000) · Biochemical Journal · doi:10.1042/bj3520233 · Cited by 54
Familial conformational diseases and dementias
Crowther, D. C. (2002) · Human Mutation · doi:10.1002/humu.10100 · Cited by 52
Nonenzymatic Glycosylation of Basement Membrane Collagen in Diabetes Mellitus
Trüeb, B., Flückiger, R., & Winterhalter, K. H. (1984) · Collagen and Related Research · doi:10.1016/s0174-173x(84)80032-1 · Cited by 45
Glucose-Modified Proteins Modulate Essential Functions and Apoptosis of Polymorphonuclear Leukocytes
Cohen, G., Rudnicki, M., Roth‐Walter, F., Niwa, T., & Diaeresisrl, W. H. H. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1261264 · Cited by 45
Greten, H. J., Kreis, I., Wiesel, K., Stier, E., Schmidt, A. M., Stern, D., Ritz, E., Waldherr, R., & Nawroth, P. P. (1996) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/11.5.786 · Cited by 44
Dialysis‐Related Amyloidosis: Pathogenesis Focusing on AGE Modification
Niwa, T. (2001) · Seminars in Dialysis · doi:10.1046/j.1525-139x.2001.00031.x · Cited by 35
Aminoguanidine and the effects of modified LDL on cultured retinal capillary cells.
Lyons, T. J., Li, W., Wojciechowski, B., Wells-Knecht, M. C., Wells‐Knecht, K. J., & Jenkins, A. J. (2000) · PubMed · Cited by 33
Symmons, M. F., Buchanan, S. G., Clarke, D. T., Jones, G., & Gay, N. J. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00809-0 · Cited by 26
Protein „AGEing” - cytotoxicity of a glycated protein increases with its degree of AGE-modification
Gasic‐Milenkovic, J., Loske, C., Deuther‐Conrad, W., & Münch, G. W. (2001) · Zeitschrift für Gerontologie und Geriatrie · doi:10.1007/s003910170018 · Cited by 25
Cited by
Stability of Protein Pharmaceuticals: An Update
Manning, M. C., Chou, D. K., Murphy, B. M., Payne, R. W., & Katayama, D. S. (2010) · Pharmaceutical Research · doi:10.1007/s11095-009-0045-6 · Cited by 1,098
The glycation of albumin: Structural and functional impacts
Rondeau, P., & Bourdon, E. (2011) · Biochimie · doi:10.1016/j.biochi.2010.12.003 · Cited by 433
Sonication of proteins causes formation of aggregates that resemble amyloid
Stathopulos, P. B., Scholz, G. A., Hwang, Y., Rumfeldt, J. A. O., Lepock, J. R., & Meiering, E. M. (2004) · Protein Science · doi:10.1110/ps.04831804 · Cited by 418
Advanced Glycation end Products, Oxidative Stress and Diabetic Nephropathy
Yamagishi, S.-I., & Matsui, T. (2010) · Oxidative Medicine and Cellular Longevity · doi:10.4161/oxim.3.2.11148 · Cited by 397
Advanced glycation end products and the kidney
Bohlender, J. M., Franke, S., Stein, G., & Wolf, G. (2005) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00398.2004 · Cited by 387
Metadata
- Authors
- Bouma, B., Kroon-Batenburg, L. M. J., Wu, Y.-P., Brünjes, B., Posthuma, G., Kranenburg, O., de Groot, P. G., Voest, E. E., & Gebbink, M. F. B. G.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2003-10
- Volume
- 278
- Issue
- 43
- Pages
- 41810-41819
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2044321635
- Cited by
- 286
- References
- 68
- FWCI
- 3.79
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.